Ensign Peak Advisors
NVRO

Ensign Peak Advisors’s NEVRO CORP. NVRO Stock Holding History

Ensign Peak Advisors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,240
Closed -$291K – 2260
2022
Q3 		$291K Hold
6,240
– – ﹤0.01% 1717
2022
Q2 		$273K Hold
6,240
– – ﹤0.01% 1708
2022
Q1 		$451K Buy
6,240
+1,430
+30% +$103K ﹤0.01% 1595
2021
Q4 		$390K Buy
+4,810
New +$482K ﹤0.01% 1718

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ensign Peak Advisors's NVRO Position: Q4 2022 in Review

Ensign Peak Advisors sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 6,240 shares — an estimated $291K sold.

Ensign Peak Advisors first reported a position in NVRO in Q4 2021 and held it in 4 quarters. The position peaked at $451K in Q1 2022. 170 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Ensign Peak Advisors reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 6,240 NEVRO CORP. shares in Q4 2022, an estimated $291K.
  • Ensign Peak Advisors first reported a position in NEVRO CORP. in Q4 2021 and held it in 4 quarters.
  • Ensign Peak Advisors's NEVRO CORP. position peaked at $451K in Q1 2022.
  • 170 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.